Recent Price Movement and Market Context
On 26 Dec 2025, Symbiox Investment & Trading Co's share price touched Rs.2, its lowest level in the past year. This price point represents a notable drop from its 52-week high of Rs.6.02. Over the last five trading sessions, the stock has recorded a cumulative return of -25.93%, indicating persistent selling pressure. Today’s decline of 4.76% further underlines the stock’s underperformance relative to its sector, which itself has seen a milder downturn of 4.46%.
The broader market, represented by the Sensex, opened lower by 183.42 points and is currently trading at 85,100.16, down 0.36%. Despite this, the Sensex remains close to its 52-week high, just 1.24% shy of 86,159.02, and is supported by bullish moving averages with the 50-day moving average positioned above the 200-day moving average. Mid-cap stocks have shown resilience, with the BSE Mid Cap index gaining 0.09% today, contrasting with the weakness seen in Symbiox Investment & Trading Co.
Technical Indicators and Moving Averages
Technical analysis reveals that Symbiox Investment & Trading Co is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This positioning suggests a sustained bearish trend over short, medium, and long-term horizons. The stock’s inability to breach these resistance levels has contributed to its slide to the current 52-week low.
Only 1% make it here. This Large Cap from the Gems, Jewellery And Watches sector passed our rigorous filters with flying colors. Be among the first few to spot this gem!
- - Highest rated stock selection
- - Multi-parameter screening cleared
- - Large Cap quality pick
Financial Performance and Growth Metrics
Symbiox Investment & Trading Co’s financial data over the past year highlights several areas of concern. The company’s return on equity (ROE) stands at an average of 0.85%, indicating limited profitability relative to shareholder equity. Operating profit has shown a modest annual growth rate of 5.22%, which is subdued compared to industry peers.
Profitability has been under pressure, with reported profits declining by 31% over the last year. The company’s earnings before interest, taxes, depreciation, and amortisation (EBITDA) have been negative, signalling challenges in generating operational cash flow. These factors contribute to the stock’s classification as risky when compared to its historical valuation averages.
Long-Term and Short-Term Performance Comparison
Over the last twelve months, Symbiox Investment & Trading Co has delivered a total return of -59.60%, significantly lagging behind the Sensex, which recorded an 8.44% return in the same period. The stock has also underperformed the BSE500 index across multiple time frames, including the last three years, one year, and three months, reflecting persistent weakness in both near-term and long-term performance.
The stock’s 52-week high of Rs.6.02 contrasts sharply with its current price, underscoring the extent of the decline. This performance gap highlights the challenges faced by the company in regaining investor confidence and market momentum.
Shareholding Pattern and Market Position
The majority of Symbiox Investment & Trading Co’s shares are held by non-institutional investors. This ownership structure may influence trading dynamics and liquidity in the stock. The company operates within the Non Banking Financial Company (NBFC) sector, which has experienced varied performance trends in recent months.
Symbiox Investment & Trading Co or something better? Our SwitchER feature analyzes this micro-cap Non Banking Financial Company (NBFC) stock and recommends superior alternatives based on fundamentals, momentum, and value!
- - SwitchER analysis complete
- - Superior alternatives found
- - Multi-parameter evaluation
Sector and Market Environment
The NBFC sector, to which Symbiox Investment & Trading Co belongs, has faced mixed conditions amid broader economic fluctuations. While some mid-cap stocks have shown resilience, the overall sector performance has been uneven. The Sensex’s proximity to its 52-week high and its bullish moving averages contrast with the subdued performance of Symbiox Investment & Trading Co, highlighting the stock’s relative weakness within its sector and the wider market.
Investors and market participants may note the divergence between the company’s stock trajectory and the broader indices, which have maintained more stable or positive trends over the same period.
Summary of Key Metrics
To summarise, Symbiox Investment & Trading Co’s stock has reached a 52-week low of Rs.2 after a sustained period of decline. The stock’s performance over the past year shows a return of -59.60%, with profits contracting by 31%. The company’s average ROE of 0.85% and modest operating profit growth of 5.22% reflect subdued financial health. Negative EBITDA and trading below all major moving averages further illustrate the challenges faced by the stock in the current market environment.
These factors collectively contribute to the stock’s current valuation and market position, underscoring the importance of closely monitoring its financial and market developments going forward.
Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year (MRP = Rs. 34,999) Start Saving Now →
